{"text": ["Alphabet", "and", "Simon", "Property", "skid", "while", "Constellation", "rises"], "created_at": "2018-10-04 20:44:32"}
{"text": ["Tech", "Stocks", "Punished", "As", "Nasdaq", "Breaks", "Support;", "Leading", "Software", "Stocks", "Nailed"], "created_at": "2018-10-04 19:45:40"}
{"text": ["Notable", "Thursday", "Option", "Activity:", "HD,", "LLY,", "ADBE"], "created_at": "2018-10-04 19:08:33"}
{"text": ["Notable", "Thursday", "Option", "Activity:", "HD,", "LLY,", "ADBE"], "created_at": "2018-10-04 19:08:33"}
{"text": ["US", "STOCKS-Wall", "St", "succumbs", "to", "soaring", "bond", "yields"], "created_at": "2018-10-04 16:12:52"}
{"text": ["XLV,", "UNH,", "MDT,", "LLY:", "ETF", "Inflow", "Alert"], "created_at": "2018-10-04 16:10:33"}
{"text": ["XLV,", "UNH,", "MDT,", "LLY:", "ETF", "Inflow", "Alert"], "created_at": "2018-10-04 16:10:33"}
{"text": ["Boehringer", "Ingelheim", "and", "Lilly", "present", "full", "results", "of", "Tradjenta\u00ae's", "CARMELINA\u00ae", "cardiovascular", "outcome", "trial"], "created_at": "2018-10-04 15:15:00"}
{"text": ["S&P", "500", "Movers:", "COTY,", "LLY"], "created_at": "2018-10-04 15:11:54"}
{"text": ["S&P", "500", "Movers:", "COTY,", "LLY"], "created_at": "2018-10-04 15:11:54"}
{"text": ["Amgen\u2019s", "Stock", "Performance", "and", "Estimates", "after", "Q3", "2018"], "created_at": "2018-10-04 14:31:25"}
{"text": ["US", "STOCKS-Wall", "St", "succumbs", "to", "soaring", "bond", "yields"], "created_at": "2018-10-04 14:23:16"}
{"text": ["Lilly's", "diabetes", "drug", "data", "impresses,", "hurts", "rival", "Novo's", "shares"], "created_at": "2018-10-04 13:55:06"}
{"text": ["US", "STOCKS-Wall", "St", "set", "to", "open", "lower", "as", "Treasury", "yields", "jump"], "created_at": "2018-10-04 13:01:05"}
{"text": ["Diabetes", "Drug&apos;s", "Results", "Push", "Lilly", "to", "Look", "at", "Obesity", "Too"], "created_at": "2018-10-04 12:57:33"}
{"text": ["The", "Daily", "Biotech", "Pulse:", "AtriCure's", "Guidance,", "Guardant", "Health", "And", "Kodiak", "To", "Debut"], "created_at": "2018-10-04 11:59:50"}
{"text": ["Eli", "Lilly&apos;s", "stock", "surges", "toward", "record", "after", "positive", "trials", "for", "diabetes", "treatments"], "created_at": "2018-10-04 11:36:00"}
{"text": ["Eli", "Lilly\u2019s", "Stock", "Performance", "and", "Estimates", "for", "Q3", "2018"], "created_at": "2018-10-04 11:32:27"}
{"text": ["Mylan", "Launches", "Its", "Generic", "Brevibloc", "Injection"], "created_at": "2018-10-04 11:30:02"}
{"text": ["Global", "Markets", "Drag", "Stocks", "Lower;", "Did", "China", "Hack", "Apple?"], "created_at": "2018-10-04 10:37:14"}
{"text": ["Boehringer", "Ingelheim", "and", "Lilly", "present", "full", "results", "from", "EASE", "Phase", "III", "program", "for", "empagliflozin", "as", "adjunct", "to", "insulin", "in", "type", "1", "diabetes"], "created_at": "2018-10-04 10:30:00"}
{"text": ["Lilly's", "Investigational", "Dual", "GIP", "and", "GLP-1", "Receptor", "Agonist", "Shows", "Significant", "Reduction", "in", "HbA1c", "and", "Body", "Weight", "in", "People", "With", "Type", "2", "Diabetes"], "created_at": "2018-10-04 10:00:00"}
{"text": ["Eli", "Lilly's", "diabetes", "drug", "shows", "promise", "in", "mid-stage", "trial"], "created_at": "2018-10-04 10:00:00"}
{"text": ["Boehringer", "Ingelheim", "&", "Eli", "Lilly:", "Empagliflozin", "Meets", "Primary", "Efficacy", "Endpoint"], "created_at": "2018-10-04 06:51:00"}
{"text": ["Boehringer", "Ingelheim", "&", "Eli", "Lilly:", "Empagliflozin", "Meets", "Primary", "Efficacy", "Endpoint"], "created_at": "2018-10-04 06:51:00"}
